Bellevue Group AG Q2 2017 Filing

Filed August 14, 2017

Portfolio Value

$845.7B

Holdings

132

Report Date

Q2 2017

Filing Type

13F-HR

All Holdings (132 positions)

#StockSharesValue% PortfolioType
101
ICPTUSDINTERCEPT PHARMACEUTICALS IN
8,500$1.0B0.12%
102
BIBPROSHARES TR
19,000$1.0B0.12%
103
UTHUNITED THERAPEUTICS CORP DEL
7,800$1.0B0.12%
104
IRTCIRHYTHM TECHNOLOGIES INC
23,500$999.0M0.12%
105
PENPENUMBRA INC
11,300$992.0M0.12%
106
PFEPFIZER INC
29,200$981.0M0.12%
107
GKOSGLAUKOS CORP
22,500$933.0M0.11%
108
HMS HLDGS CORP
50,000$925.0M0.11%
109
PODDINSULET CORP
17,000$872.0M0.10%
110
NKTREURNEKTAR THERAPEUTICS
43,000$841.0M0.10%
111
ENVISION HEALTHCARE CORP
13,026$816.0M0.10%
112
QUOTIENT LTD
110,000$810.0M0.10%
113
TDOCTELADOC INC
22,500$781.0M0.09%
114
COTIVITI HLDGS INC
21,000$780.0M0.09%
115
CEMPRA INC
165,000$759.0M0.09%
116
MEDICINES CO
19,500$741.0M0.09%
117
NVROEURNEVRO CORP
9,700$722.0M0.09%
118
VAREURVARIAN MED SYS INC
7,000$722.0M0.09%
119
SGRYSURGERY PARTNERS INC
31,000$705.0M0.08%
120
HCMHUTCHISON CHINA MEDTECH LTD
29,242$682.0M0.08%
121
DVADAVITA INC
10,000$648.0M0.08%
122
GW PHARMACEUTICALS PLC
6,000$602.0M0.07%
123
TBPHTHERAVANCE BIOPHARMA INC
14,428$575.0M0.07%
124
TRHCEURTABULA RASA HEALTHCARE INC
36,907$555.0M0.07%
125
ITCIEURINTRA CELLULAR THERAPIES INC
40,000$497.0M0.06%
126
OBALON THERAPEUTICS INC
45,000$446.0M0.05%
127
WEBMD HEALTH CORP
7,400$434.0M0.05%
128
CELLDEX THERAPEUTICS INC NEW
160,000$395.0M0.05%
129
ALDER BIOPHARMACEUTICALS INC
33,000$378.0M0.04%
130
ESPRESPERION THERAPEUTICS INC NEW
8,000$370.0M0.04%
131
MYGNMYRIAD GENETICS INC
13,000$336.0M0.04%
132
AAC HLDGS INC
45,000$312.0M0.04%
PreviousPage 2 of 2